Press releases

09 Oct 2014

Synthon Announces Filing of Glatiramer Acetate 40 mg/mL ANDA Containing a Paragraph IV Certification

15 Apr 2014

Synthon obtains European approvals for sevelamer

27 Mar 2014

Synthon announces successful outcome of the Phase III GATE study with its generic glatiramer acetate

Press contact

Sebastiaan van den Bovenkamp, Communications specialist
T +31(0)6 205 702 88
E communications@synthon.com